According to the recent study the migraine drugs market is projected to reach an estimated $XX billion by 2028 from $XX billion in 2023, at a CAGR of 12% to 15% from 2023 to 2028. Growth in this market is primarily driven by growing cases of migraine due to stress, hormonal changes, and lifestyle diseases, increased uptake of novel drug classes, launch of calcitonin gene-related peptide (CGRP)-based therapies, and growing awareness programs regarding the prevention and treatment of migraine.
Browse XX figures /
charts and XX tables in this 150 -page report to understand trends,
opportunities and forecast in migraine drugs market by product type (acute
migraine treatment and preventive migraine treatment), route of administration
(oral, injectables, and others), distribution channel (hospital pharmacies,
retail pharmacies and online pharmacies), and region (North America, Europe,
Asia Pacific, and the Rest of the World).
Download sample report by clicking
on below link
https://www.lucintel.com/migraine-drugs-market.aspx
“Acute migraine treatment market is
expected to remain the largest segment during the forecast period.”
Based on product type,
the migraine drugs market is segmented into acute migraine treatment and preventive
migraine treatment. Lucintel forecasts that the acute migraine treatment market
is expected to remain the largest segment due to ease of self-administration in
case of patients with symptoms of nausea and vomiting along with migraine and
growing utilization in combination with preventive treatments.
“Within the migraine drugs market, the online pharmacy segment is
expected to remain the largest distribution channel.”
Based on distribution
channel the online pharmacy segment is expected to witness the highest growth
over the forecast period due to because it provides migraine drugs through
e-commerce platforms which is convenient, gives privacy of buying, hassel-free,
and saves time by allowing people to refrain from waiting in queues. It is
specifically helpful for individuals who live far from a regular pharmacy, the
elderly, the crippled, and those who work extensively, this technique of
receiving medication is both very simple and quick. In addition, the cost of
delivery is far less than the expense of traveling to a regular pharmacy hence,
provides additional benefit.
“Asia pacific will dominate the migraine drugs market in near
future.”
APAC will remain the
fastest growing region due to rising prevalence of migraine in people due to
increasing stress, work pressure, changing lifestyle, and consumption of
alcohol, growing public awareness about the disease, rising healthcare
spending, and accessibility to healthcare facilities.
Download Brochure of this report by clicking on https://www.lucintel.com/migraine-drugs-market.aspx.
Major players of
migraine drugs market are adopting various growth strategies like new product
launches, expansions, merger and acquisitions, partnerships, agreements, and
collaborations to expand their presence in this market. Allergan, Abbott
Laboratories, AstraZeneca, Endo International, Eisai Co., Impax Laboratories,
GlaxoSmithKline, Johnson & Johnson, Pfizer Inc., Merck & Co., and
Sanofi SA are among the major migraine drugs providers.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or click on this link https://www.lucintel.com/migraine-drugs-market.aspx or helpdesk@lucintel.com.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times. For further information, visit www.lucintel.com.
Contact:
Brandon Fitzgerald
Lucintel
Dallas, Texas, USA
Email: brandon.fitzgerald@lucintel.com
Tel. 972.636.5056
Cell: 303.775.0751
Related reports
Mhealth
Solution Market:
For more details click here https://www.lucintel.com/mhealth-solution-market.aspx
Minimally
Invasive Surgery Market:
For more details click here https://www.lucintel.com/minimally-invasive-surgery-market.aspx
Medical Aesthetic Market:
For more details click here https://www.lucintel.com/medical-aesthetic-market.aspx
Neurostimulation Market:
For more details click here https://www.lucintel.com/neurostimulation-market.aspx
Nuclear Medicine/Radiopharmaceutical Market:
For more details click here https://www.lucintel.com/nuclear-medicine-radiopharmaceutical-market.aspx
Liquid Biopsy Market:
For more details click here https://www.lucintel.com/liquid-biopsy-market.aspx
Digital
Fitness Market:
For more details click here https://www.lucintel.com/digital-fitness-market.aspx
Digital X-Ray Market:
For more details click here https://www.lucintel.com/digital-xray-market.aspx
Medical
Robot Market:
For more details click here https://www.lucintel.com/medical-robot-market.aspx
Healthcare IT Market:
No comments:
Post a Comment